471 related articles for article (PubMed ID: 2703529)
21. Down-regulation of rat hepatic microsomal cytochromes P-450 in microvesicular steatosis induced by orotic acid.
Su GM; Sefton RM; Murray M
J Pharmacol Exp Ther; 1999 Dec; 291(3):953-9. PubMed ID: 10565810
[TBL] [Abstract][Full Text] [Related]
22. Inhibition and inactivation of constitutive cytochromes P450 in rat liver by parathion.
Butler AM; Murray M
Mol Pharmacol; 1993 Jun; 43(6):902-8. PubMed ID: 8316222
[TBL] [Abstract][Full Text] [Related]
23. Pretranslational down-regulation of male specific hepatic P450s after portal bypass.
Jiang XM; Cantrill E; Farrell GC; Murray M
Biochem Pharmacol; 1994 Aug; 48(4):701-8. PubMed ID: 8080442
[TBL] [Abstract][Full Text] [Related]
24. Selective inactivation of four rat liver microsomal androstenedione hydroxylases by chloramphenicol analogs.
Stevens JC; Halpert J
Mol Pharmacol; 1988 Jan; 33(1):103-10. PubMed ID: 3336347
[TBL] [Abstract][Full Text] [Related]
25. In vitro metabolism of tirilazad mesylate in male and female rats. Contribution of cytochrome P4502C11 and delta 4-5 alpha-reductase.
Wienkers LC; Steenwyk RC; Mizsak SA; Pearson PG
Drug Metab Dispos; 1995 Mar; 23(3):383-92. PubMed ID: 7628305
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of male-specific cytochrome P450s 2C11 and 3A2 in bile duct-ligated male rats: importance to reduced hepatic content of cytochrome P450 in cholestasis.
Chen J; Murray M; Liddle C; Jiang XM; Farrell GC
Hepatology; 1995 Aug; 22(2):580-7. PubMed ID: 7635428
[TBL] [Abstract][Full Text] [Related]
27. Imprinting of hepatic microsomal cytochrome P-450 enzyme activities and cytochrome P-450IIC11 by peripubertal administration of testosterone in female rats.
Cadario BJ; Bellward GD; Bandiera S; Chang TK; Ko WW; Lemieux E; Pak RC
Mol Pharmacol; 1992 May; 41(5):981-8. PubMed ID: 1588929
[TBL] [Abstract][Full Text] [Related]
28. Monoclonal antibodies of differentiating specificities as probes of cytochrome P450h (2C11).
Ryan DE; Thomas PE; Levin W; Maines SL; Bandiera S; Reik LM
Arch Biochem Biophys; 1993 Mar; 301(2):282-93. PubMed ID: 7681658
[TBL] [Abstract][Full Text] [Related]
29. Hepatic testosterone metabolism in male rats with portal bypass.
Farrell G; Koltai A
Gastroenterology; 1988 Aug; 95(2):425-33. PubMed ID: 3391370
[TBL] [Abstract][Full Text] [Related]
30. Identification of the cytochrome P-450 isozymes responsible for testosterone oxidation in rat lung, kidney, and testis: evidence that cytochrome P-450a (P450IIA1) is the physiologically important testosterone 7 alpha-hydroxylase in rat testis.
Sonderfan AJ; Arlotto MP; Parkinson A
Endocrinology; 1989 Aug; 125(2):857-66. PubMed ID: 2752981
[TBL] [Abstract][Full Text] [Related]
31. Characterization of recombinant CYP2C11: a vitamin D 25-hydroxylase and 24-hydroxylase.
Rahmaniyan M; Patrick K; Bell NH
Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E753-60. PubMed ID: 15585593
[TBL] [Abstract][Full Text] [Related]
32. Inhibition and metabolite complexation of rat hepatic microsomal cytochrome P450 by tricyclic antidepressants.
Murray M; Field SL
Biochem Pharmacol; 1992 May; 43(10):2065-71. PubMed ID: 1599495
[TBL] [Abstract][Full Text] [Related]
33. 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) modulates rat liver microsomal cyclophosphamide and ifosphamide activation by suppressing cytochrome P450 2C11 messenger RNA levels.
Chang TK; Chen H; Waxman DJ
Drug Metab Dispos; 1994; 22(5):673-9. PubMed ID: 7835216
[TBL] [Abstract][Full Text] [Related]
34. Flumecinol, a novel inducer of testosterone 16 alpha-hydroxylation in male rats.
Silva M; Gil L
Xenobiotica; 1990 Jul; 20(7):689-97. PubMed ID: 2238704
[TBL] [Abstract][Full Text] [Related]
35. Catalytic selectivity and mechanism-based inactivation of stably expressed and hepatic cytochromes P450 2B4 and 2B5: implications of the cytochrome P450 2B5 polymorphism.
Grimm SW; Dyroff MC; Philpot RM; Halpert JR
Mol Pharmacol; 1994 Dec; 46(6):1090-9. PubMed ID: 7808429
[TBL] [Abstract][Full Text] [Related]
36. Monoclonal antibodies to rat liver cytochrome P-450 2c/RLM5 that regiospecifically inhibit steroid metabolism.
Park SS; Waxman DJ; Lapenson DP; Schenkman JB; Gelboin HV
Biochem Pharmacol; 1989 Sep; 38(18):3067-74. PubMed ID: 2783161
[TBL] [Abstract][Full Text] [Related]
37. Constitutive forms of rabbit-liver microsomal cytochrome P-450: enzymatic diversity, polymorphism and allosteric regulation.
Johnson EF; Schwab GE
Xenobiotica; 1984; 14(1-2):3-18. PubMed ID: 6609490
[TBL] [Abstract][Full Text] [Related]
38. Platinum anticancer drugs modulate P-450 mRNA levels and differentially alter hepatic drug and steroid hormone metabolism in male and female rats.
LeBlanc GA; Sundseth SS; Weber GF; Waxman DJ
Cancer Res; 1992 Feb; 52(3):540-7. PubMed ID: 1732040
[TBL] [Abstract][Full Text] [Related]
39. Cytochrome P450 metabolism of estradiol in hamster liver and kidney.
Hammond DK; Zhu BT; Wang MY; Ricci MJ; Liehr JG
Toxicol Appl Pharmacol; 1997 Jul; 145(1):54-60. PubMed ID: 9221823
[TBL] [Abstract][Full Text] [Related]
40. In vitro and in vivo studies of the effect of vitamin E on microsomal cytochrome P450 in rat liver.
Murray M
Biochem Pharmacol; 1991 Nov; 42(11):2107-14. PubMed ID: 1958229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
